13F filer · CIK 1666737
Tappan Street Partners LLC
New York, NY · filing since Q4 2015 · last filing Nov 14, 2017
Reported value
$35.7M
+$1.5M vs prior
Positions
8
New / sold out
3 / 2
Added / reduced
1 / 2
Turnover
36.3%
buys $12.7M · sells $12.9M
Top-10 weight
100.0%
Biggest buys vs Q2 2017
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | PEREGRINE PHARMACEUTICALS IN | +2,871,000 | – | +$9.0M |
| New | RECRO PHARMA INC | +234,902 | – | +$2.1M |
| New | ENERGY RECOVERY INC | +178,592 | – | +$1.4M |
| Added | HILL INTERNATIONAL INC | +30,000 | +3.3% | +$142.5K |
Biggest sells vs Q2 2017
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | PEREGRINE PHARMACEUTICALS INC | -11,593,530 | -100.0% | $-7.0M |
| Sold out | SPARTON CORP | -180,000 | -100.0% | $-4.0M |
| Reduced | ADIENT PLC | -15,000 | -14.3% | $-1.3M |
| Reduced | HUDSON TECHNOLOGIES INC | -83,499 | -15.2% | $-652.1K |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q3 2017
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | PEREGRINE PHARMACEUTICALS INCOM PAR | 2,871,000 | $9.0M | 25.25% |
| 2 | ADIENT PLCORD SHS | 90,000 | $7.6M | 21.18% |
| 3 | VOYA FINL INCCOM | 165,000 | $6.6M | 18.44% |
| 4 | HILL INTERNATIONAL INCCOM | 930,000 | $4.4M | 12.38% |
| 5 | HUDSON TECHNOLOGIES INCCOM | 466,501 | $3.6M | 10.21% |
| 6 | RECRO PHARMA INCCOM | 234,902 | $2.1M | 5.91% |
| 7 | ENERGY RECOVERY INCCOM | 178,592 | $1.4M | 3.95% |
| 8 | ALPHABET INCCAP STK CL C | 1,000 | $959.0K | 2.69% |